INNOVATIVE
SOLUTIONS FOR
INHALATION SAFETY
ImmuONE specialises in human alveolar macrophage responses and epithelial cell culture platforms

IN VITRO INNOVATION SERVICES
FOR EMPOWERED DECISION MAKING
APPLICATIONS OF OUR
TESTING TOOLS
We are exploring the breadth of applications for our products and services to help you make better, earlier decisions for your future products and chemicals. Our highly experienced team completes the in-house testing services, and we are partnered with other laboratories to facilitate your study requests.

IN VITRO CELL CULTURES
Our expertise covers the immune system, the lower airways of the lung and the creation of 3D lung in vitro models to help assess the effects of chemicals inhaled by humans and animals.

SERVICES
Our aim is to provide better toxicity analysis and design bespoke assays with our customers supporting them throughout the entire process

SHIPPING POSSIBILITIES
All shipping possibilities are discussed with our customers to make sure their needs are fulfilled
OUR LATEST NEWS AND PRESS RELEASES
Navigating Life and Cell Transportation with ImmuONE’s Amjad Saeed
Further development of the ImmuPHAGE™ model has been the focus of Amjad’s work during his time at ImmuONE. This model is composed of alveolar macrophage-like cells which are assembled in vitro in well plates and closely mimic the form and function of their human counterparts found within the alveoli of the deep lung.
Nurturing Tomorrow’s Biotech Leaders: A Conversation with ImmuONE’s Student Interns
At ImmuONE, we believe in fostering the growth and development of young talents in the field of biotechnology. Our commitment to nurturing bright minds extends beyond cutting-edge research; it’s about shaping the future of healthcare by empowering the leaders of tomorrow. We offer secondary school students valuable experiences through initiatives like the Nuffield Research Placements, which allow young people to find out what it’s like to work in a real biotech company and engage in a meaningful scientific project. Today, we’d like to introduce two of our promising students, Beverley Twum and Riqza Shad, who recently embarked on a two-week placement journey with us. Nilab Hydare, pre-clinical scientist at ImmuONE, skillfully led the project and served as a supportive mentor and supervisor to the students. Their guidance and expertise were instrumental in the success of this endeavor. They’ve agreed to share their insights and experiences, offering a glimpse into what they’ve learned at ImmuONE.
Improving safety assessments of inhaled drugs with ImmuONE’s high content image analysis approaches
More than half of aerosol medicines under development are terminated due to safety concerns. ImmuONE’s high content imaging or cell painting assays are proven to accurately predict the safety of inhaled compounds by quantifying mechanism-linked morphological and biochemical characteristics within cells, contributing to faster, more informed decision making in the early stages of inhaled drug development.